首页> 美国卫生研究院文献>Bioinformatics >Enhancing the drug discovery process: Bayesian inference for the analysis and comparison of dose–response experiments
【2h】

Enhancing the drug discovery process: Bayesian inference for the analysis and comparison of dose–response experiments

机译:增强药物发现过程:贝叶斯推理用于剂量反应实验的分析和比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MotivationThe efficacy of a chemical compound is often tested through dose–response experiments from which efficacy metrics, such as the IC50, can be derived. The Marquardt–Levenberg algorithm (non-linear regression) is commonly used to compute estimations for these metrics. The analysis are however limited and can lead to biased conclusions. The approach does not evaluate the certainty (or uncertainty) of the estimates nor does it allow for the statistical comparison of two datasets. To compensate for these shortcomings, intuition plays an important role in the interpretation of results and the formulations of conclusions. We here propose a Bayesian inference methodology for the analysis and comparison of dose–response experiments.
机译:动机通常通过剂量反应实验来测试化合物的功效,从中可以得出功效指标,例如IC50。 Marquardt-Levenberg算法(非线性回归)通常用于计算这些指标的估计值。然而,分析是有限的,并且可能导致有偏见的结论。该方法不评估估计的确定性(或不确定性),也不允许对两个数据集进行统计比较。为了弥补这些缺点,直觉在结果的解释和结论的表述中起着重要的作用。我们在此提出一种贝叶斯推理方法,用于分析和比较剂量反应实验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号